Livento Group (OTCMKTS:NUGN) and Innovid (NYSE:CTV) Head to Head Review

Livento Group (OTCMKTS:NUGN) and Innovid (NYSE:CTV) are both small-cap multi-sector conglomerates companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk.

Insider & Institutional Ownership

0.4% of Livento Group shares are owned by institutional investors. Comparatively, 25.5% of Innovid shares are owned by institutional investors. 9.9% of Innovid shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Livento Group and Innovid’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Livento Group	$2.01 million	4.55	-$6.55 million	N/A	N/A
Innovid	$139.88 million	1.79	-$31.91 million	($0.21)	-8.24

Livento Group has higher earnings, but lower revenue than Innovid.

Volatility & Risk

Livento Group has a beta of 5.48, indicating that its stock price is 448% more volatile than the S&P 500. Comparatively, Innovid has a beta of 3.14, indicating that its stock price is 214% more volatile than the S&P 500.

Profitability

This table compares Livento Group and Innovid’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Livento Group	-191.71%	-8.11%	-7.43%
Innovid	-20.24%	-7.81%	-6.18%

Analyst Ratings

This is a breakdown of recent ratings for Livento Group and Innovid, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Livento Group	0	0	0	0	N/A
Innovid	0	1	2	0	2.67

Innovid has a consensus price target of $2.70, suggesting a potential upside of 56.07%. Given Innovid’s higher possible upside, analysts plainly believe Innovid is more favorable than Livento Group.

Summary

Innovid beats Livento Group on 8 of the 11 factors compared between the two stocks.

About Livento Group

Livento Group, Inc. engages in the film and television production business. It is also involved in the artificial intelligence and machine learning technology business; development and licensing of Elisee, a software product that can capture data and create predictive behavior based on client inputs that assist the client in establishing its investment portfolio; and real estate finance and development activities. The company was formerly known as NuGene International, Inc. and changed its name to Livento Group, Inc. in June 2022. Livento Group, Inc. is headquartered in New York, New York.

About Innovid

Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies. The company serves consumer packaged goods, pharmaceutical and healthcare, retail, financial services, and automotive and technology industries; third party agencies; and publishers in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Innovid Corp. was incorporated in 2007 and is headquartered in New York, New York.